Rhythm Pharmaceuticals, Inc. (RYTM) Social Stream



Rhythm Pharmaceuticals, Inc. (RYTM): $24.50

0.63 (+2.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RHYTHM PHARMACEUTICALS INC (RYTM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RYTM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 3 $50 $17 $38 $23.87 59.2%
2021-11-19 3 $45 $15 $29.25 $23.87 22.54%
2021-12-01 4 $45 $15 $29.25 $23.87 22.54%
2021-12-08 5 $45 $15 $29.4 $23.87 23.17%
2022-01-26 5 $40 $10 $23.75 $23.87 -0.5%
2022-02-07 5 $40 $10 $23 $23.87 -3.64%
2022-02-17 5 $40 $12 $22.8 $23.87 -4.48%
2022-02-28 5 $40 $10 $21.4 $23.87 -10.35%
2022-03-01 5 $40 $9 $21.2 $23.87 -11.19%
2022-03-02 6 $40 $9 $21.2 $23.87 -11.19%
2022-03-03 6 $40 $9 $21.5 $23.87 -9.93%
2022-04-06 6 $40 $10 $21.666 $23.87 -9.23%
2022-05-05 6 $40 $8 $21.333 $23.87 -10.63%
2022-05-06 6 $40 $7 $21.166 $23.87 -11.33%
2022-05-24 7 $40 $7 $19.142 $23.87 -19.81%
2022-06-07 7 $40 $4 $18 $23.87 -24.59%
2022-06-22 8 $40 $4 $19.125 $23.87 -19.88%
2022-08-02 8 $40 $6 $22 $23.87 -7.83%
2022-08-03 8 $40 $6 $23.875 $23.87 0.02%
2022-08-05 8 $40 $6 $25.5 $23.87 6.83%
2022-08-13 8 $40 $16 $28.25 $23.87 18.35%
2022-08-23 8 $40 $16 $28.875 $23.87 20.97%
2022-09-17 8 $40 $16 $29.25 $23.87 22.54%

The Trend in the Analyst Price Target


RYTM's average price target has moved up $8.05 over the prior 28 weeks.

Over the past 45 weeks, RYTM's average upside potential has been 190.57%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-06 6 40 10 21.666 9.80 121.08%
2022-05-03 6 40 8 21.333 6.13 248.01%
2022-06-22 8 40 4 19.125 4.77 300.94%
2022-08-03 8 40 6 23.875 17.53 36.2%
2022-08-08 8 40 16 28.250 21.13 33.7%

RYTM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.63 5 1 2 0 0 8

The Trend in the Broker Recommendations


RYTM's average broker recommendation rating improved by 1.71 over the prior 43 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RYTM as an investment opportunity.

  • RYTM has a lower variance in analysts' estimates than -2409.71% of all US stocks.
  • In terms of how RHYTHM PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 153.63% of that group.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, RHYTHM PHARMACEUTICALS INC's number of analysts covering the stock is higher than 1941.11% of them.
  • RYTM has a higher average analyst price target than 1606.99% of stocks in the small market cap category.

Stocks similar to RHYTHM PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RXDX, RPTX, and RNA.

Is RYTM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4386 seconds.